Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Letter February 4 2025
ICE polychemotherapy is an efficient salvage treatment in relapsed/refractory primary central nervous system lymphoma.
Research Article February 4 2025
CD19.CAR-T cell-derived extracellular vesicles express CAR and kill leukemic cells, contributing to antineoplastic therapy
Letter February 4 2025
Estimating rare genetic disease prevalence: a challenging task
Letter February 4 2025
Distress and Symptom Burden in Patients with Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma
Research Article January 30 2025
Impact of Vein-to-vein Time in Patients With R/R LBCL Treated With Axicabtagene Ciloleucel
Research Article January 30 2025
Six-month Rituximab-Lenalidomide regimen in advanced untreated Follicular Lymphoma: SAKK 35/10 Trial 10-year Update
Research Article January 30 2025
A Model of Zymogen Factor XII: Insights into Protease Activation
Research Article January 28 2025
Deciphering the complex clonal heterogeneity of polycythemia vera and the response to interferon alpha
Research Article January 28 2025
Outcome of high-grade B-cell lymphoma compared to other large B-cell lymphoma after CAR-T rescue. A DESCAR-T LYSA study
Research Article January 28 2025
Efficacy and safety of dapsone in adult primary immune thrombocytopenia
Review Article January 28 2025
Hepatosplenic T-cell lymphoma in children and adolescents
Research Article January 24 2025
Cutaneous dysbiosis characterizes the post-allogeneic hematopoietic stem cell transplantation period
Review Article January 24 2025
Audit of B-cell Cancer Genes
Research Article January 24 2025
ACQUIRED MUTATIONS IN PATIENTS WITH RELAPSED/REFRACTORY CLL WHO PROGRESSED IN THE ALPINE STUDY
Research Article January 24 2025
TP53 Mutant Variant Allele Frequency and Cytogenetics Determine Prognostic Groups in MDS/AML for Transplantation
Review Article January 24 2025
Systemic Mastocytosis: Current Status and Challenges in 2024
Research Article January 18 2025
Molecular clustering on ctDNA improves the prognostic stratification of DLBCL patients compared to ctDNA levels
Letter January 18 2025
PRIMARY CUTANEOUS CD8+ AGGRESSIVE EPIDERMOTROPIC CYTOTOXIC T-CELL LYMPHOMA WITH NOVEL FGFR1 FUSION TREATED WITH PEMIGATINIB
Research Article January 18 2025
PRMT5 Inhibition Reduces Hyperinflammation in a Murine Model of Secondary Hemophagocytic Lymphohistiocytosis (HLH)
Research Article January 18 2025
Final Analysis of the Phase 1b Chemotherapy And Venetoclax in Elderly Acute Myeloid Leukaemia Trial (CAVEAT)
Research Article January 18 2025
Definitions and use of tumour bulk in phase 3 lymphoma trials: a comprehensive literature review
Research Article January 16 2025
Stroke Prevention in Hispanic Children with Sickle Cell Anemia: the SACRED trial
Research Article January 16 2025
TP53 Mutations are Associated with CD19 Negative Relapse and Inferior Outcomes after Blinatumomab in Adults with ALL
Research Article January 16 2025
Phase 1 Study of Quercetin, a Natural Antioxidant in Children and Young Adults with Fanconi Anemia (FA)
Research Article January 16 2025
Phase I study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult B-ALL patients
Review Article January 15 2025
Current developments in T-cell receptor therapy for Acute Myeloid Leukaemia
Research Article January 15 2025
N-glycan shielded CUB domains of ADAMTS13 prevent binding of C-terminal antibodies in patients with immune-mediated TTP
Letter January 15 2025
Thalassemia carriers exhibit reduced expression of CD234 on erythrocytes and levels of malaria-associated chemokines
Research Article January 14 2025
Impacts of donor age and HLA mismatch on HCT outcomes differ according to the donor CMV serostatus in unrelated allo-HCT
Research Article January 14 2025
Large clones of Clonal Hematopoiesis affect outcome in Mantle Cell Lymphoma: Results from The FIL MCL0208 Clinical Trial
Letter January 9 2025
Treatment holidays in patients with Erdheim-Chester disease receiving vemurafenib: a prospective pilot study
Research Article January 7 2025
Extended clinical phenotypes and treatment modalities in 32 JAGN1-deficient patients. A multicenter study by EBMT IEWP
Research Article January 7 2025
Pre-treatment Pulmonary Function Testing Has Limited Utility In B-cell Lymphoma Treated with CD19 CAR T-cells
Research Article January 7 2025
Patient-Reported Improvements in Patients with PNH Treated with Iptacopan from Two Phase 3 Studies
Research Article January 7 2025
Unraveling antibody-induced structural dynamics in the ADAMTS13 CUB1-2 domains via HDX-MS
Research Article January 7 2025
Maximum Tumor Diameter is Associated with Relapse Risk in Limited-Stage Hodgkin Lymphoma: An International Study
Research Article December 20 2024
Platelet spleen tyrosine kinase is a key regulator of anti-PF4 antibody-induced immunothrombosis
Research Article December 11 2024
Safety and Efficacy of Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma in a Multinational Real-World Study
Research Article November 15 2024
ATP citrate lyase is an essential player in the metabolic rewiring induced by PTEN loss during T-ALL development.
Research Article August 12 2024
Feasibility and Favorable Responses Following Investigational CAR T-Cell Therapy for Relapsed and Refractory Infant ALL
Page 3 of 3
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals